# OnCo record checkmate-9dw (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/checkmate-9dw/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "checkmate-9dw", "NCT04039607" ;
  schema:name "CheckMate 9DW"@en ;
  schema:description "Dual immune checkpoint blockade gave the longest median survival yet seen in a first-line liver cancer trial."@en ;
  schema:url <https://onco.cc/trials/checkmate-9dw/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04039607>, <https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00403-9/fulltext> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2019-09-30" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/hcc-advanced/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/ctla4/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/> .